Literature DB >> 16010455

Non-functioning pituitary carcinoma.

Petra Nadja Elsässer Imboden1, François-Xavier Borruat2, Nicolas De Tribolet3, Kathleen Meagher-Villemure4, Alesia Pica5, Fulgencio Gomez6,7.   

Abstract

Null-cell carcinomas of the pituitary are extremely rare. We describe a 41-year-old woman with a large adenohypophyseal neoplasm presenting as a primary nonfunctioning tumor without pituitary insufficiency. Signs of mass effect with progressive unilateral ocular motility disorders and anterior pituitary failure developed rapidly. Histopathological examination of the trans-sphenoidally removed tumor showed a primary pituitary null cell tumor with high mitotic index. Pituitary carcinoma was suspected because of rapid relapse of ocular motility disorders and of intra-sellar tumor growth after surgery. Radiotherapy of the sellar and parasellar area with a total dose of 59.4 Gy was performed, achieving marked tumor reduction and a significant improvement of ocular motility disorders. However, 6.5 months after presentation the patient rapidly declined and died of carcinomatous meningitis. Less than 100 pituitary carcinomas have been published so far, most of them as single-case reports, and endocrine, immunohistochemical, and ultrastructural data have not been described in the majority of cases. At presentation, there are no specific symptoms that allow to distinguish benign from malignant tumor. Prognosis is poor, since no curative treatment has been established, but aggressive surgery and radiotherapy has been recommended. Our case highlights the poor prognosis of nonfunctioning pituitary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16010455     DOI: 10.1007/s11102-005-3411-3

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  22 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  Pituitary carcinoma containing gonadotropins: treatment by radical excision and cytotoxic chemotherapy: case report.

Authors:  I E McCutcheon; D R Pieper; G N Fuller; R S Benjamin; K E Friend; R F Gagel
Journal:  Neurosurgery       Date:  2000-05       Impact factor: 4.654

3.  Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

Authors:  K Thapar; K Kovacs; B W Scheithauer; L Stefaneanu; E Horvath; P J Pernicone; D Murray; E R Laws
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

4.  [Diagnosis, treatment and course of hypophyseal tumors. Retrospective study of 123 cases].

Authors:  B Giorgis; R Campiche; P Burckhardt; F Gómez
Journal:  Schweiz Med Wochenschr       Date:  1986-10-18

5.  Pituitary carcinoma: a clinicopathologic study of 15 cases.

Authors:  P J Pernicone; B W Scheithauer; T J Sebo; K T Kovacs; E Horvath; W F Young; R V Lloyd; D H Davis; B L Guthrie; W C Schoene
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

Review 6.  Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.

Authors:  R B Mountcastle; B S Roof; R K Mayfield; D B Mordes; J Sagel; P J Biggs; S E Rawe
Journal:  Am J Med Sci       Date:  1989-08       Impact factor: 2.378

Review 7.  Long-term survival with ACTH-secreting carcinoma of the pituitary: a case report and review of the literature.

Authors:  Rita E Landman; Melvin Horwith; Ralph E Peterson; Alexander G Khandji; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

8.  Pituitary metastasis: incidence in cancer patients and clinical differentiation from pituitary adenoma.

Authors:  M B Max; M D Deck; D A Rottenberg
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

9.  Assessment of Mitotic Activity in Pituitary Adenomas and Carcinomas.

Authors:  Kamal Thapar; Yukio Yamada; Bernd Scheithauer; Kalman Kovacs; Shozo Yamada; Lucia Stefaneanu
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  Prolactin cell carcinoma of the pituitary. Clinicopathologic, immunohistochemical, and ultrastructural study of a case with cranial and extracranial metastases.

Authors:  B W Scheithauer; R V Randall; E R Laws; K T Kovacs; E Horvath; M D Whitaker
Journal:  Cancer       Date:  1985-02-01       Impact factor: 6.860

View more
  6 in total

Review 1.  Pituitary carcinoma with intraspinal metastasis: report of two cases and review of the literature.

Authors:  Yin Qian Wang; Tao Fan; Xin Gang Zhao; Cong Liang; Xue Ling Qi; Jian Yi Li
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma).

Authors:  Nèle Lenders; Ann McCormack
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

3.  Atypical pituitary adenoma with malignant features.

Authors:  Adam N Mamelak; John D Carmichael; Patricia Park; Sergei Bannykh; Xuemo Fan; H Vivien Bonert
Journal:  Pituitary       Date:  2011-03       Impact factor: 4.107

Review 4.  Pituitary carcinoma - case series and review of the literature.

Authors:  Stephanie Du Four; Jorn Van Der Veken; Johnny Duerinck; Elle Vermeulen; Corina E Andreescu; Michael Bruneau; Bart Neyns; Van Velthoven; Brigitte Velkeniers
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

5.  Orbital metastasis of pituitary growth hormone secreting carcinoma causing lateral gaze palsy.

Authors:  Rohan R Lall; Stephen F Shafizadeh; Kyung-Hwa Lee; Qinwen Mao; Minesh Mehta; Jeffrey Raizer; Bernard R Bendok; James P Chandler
Journal:  Surg Neurol Int       Date:  2013-04-18

6.  Leptomeningeal Carcinomatosis: A Clinical Dilemma in Neuroendocrine Neoplasms.

Authors:  Leonidas Apostolidis; Jörg Schrader; Henning Jann; Anja Rinke; Sebastian Krug
Journal:  Biology (Basel)       Date:  2021-03-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.